Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
Abstract Age-related macular degeneration (AMD) is a leading cause of severe vision loss worldwide, with a global prevalence that is predicted to substantially increase. Identifying early biomarkers indicative of progression risk will improve our ability to assess which patients are at greatest risk...
Hlavní autoři: | Eleonora M. Lad, Robert P. Finger, Robyn Guymer |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Adis, Springer Healthcare
2023-09-01
|
Edice: | Ophthalmology and Therapy |
Témata: | |
On-line přístup: | https://doi.org/10.1007/s40123-023-00807-9 |
Podobné jednotky
-
Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration
Autor: Treefa Shwani, a další
Vydáno: (2023-11-01) -
Age-Related Macular Degeneration: Classification and Pathogenesis
Autor: İmren Akkoyun
Vydáno: (2014-12-01) -
Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
Autor: Reem H. ElSheikh, a další
Vydáno: (2022-11-01) -
Serum lipids in adults with late age-related macular degeneration: a case-control study
Autor: Richard D. Semba, a další
Vydáno: (2019-01-01) -
Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
Autor: João Estarreja, a další
Vydáno: (2024-07-01)